Middle East & Africa Cardiac Monitoring Market - Segmented by Type of Device and Geography - Growth, Trends, and Forecast (2018 - 2023)
The Middle East & Africa cardiac monitoring market is expected to register a CAGR of 5.0% during the forecast period of 2018–2023. Cardiac monitoring devices are used to monitor and diagnose various abnormalities or disorders of the heart and the overall cardiovascular systems.
Rise in Incidences of Cardiovascular Diseases
Countries in the Middle East & Africa have a high incidence of cardiac diseases. According to WHO, cardiovascular disease accounts for the majority of deaths in Oman and Kuwait, which are approximately 49% and 46% of the total deaths annually. The rate of deaths in Saudi Arabia, the United Arab Emirates, Bahrain, and Qatar is also high, estimated to be 42%, 38%, 32% and 23% respectively. The rate of diagnosis of cardiovascular diseases is increasing over time due to high incidence rate of cardiac diseases and the need to control mortality rate by early diagnosis, and treatment for CVD with the help of cardiac monitoring devices. Hence, rise in the incidence of cardiovascular diseases drives the market. The other factors, such as investments in R&D for innovative product development, ease of use and portability in devices, and the demand for home-based, point of care and remote monitoring cardiac systems are the major drivers for the market.
Risk of Infection form Implantable Monitoring Devices
Cardiac monitoring device is used by patients who require continuous monitoring of the heart for better treatment. Monitoring the cardiac output is a common practice in patients who undergo surgeries, as they will be under anesthesia and critical care. Cardiac implantable devices are used for related cardiac surgeries to monitor heart rate continuously. The patients who undergo any invasive procedures are at a risk of infection. The rising rate of infections due to these devices has tremendous economic implications on hospitals. Patients who are implanted with these monitoring devices are likely to require prolonged hospital stays, and the related costs rack up quickly. However, minimally invasive cardiac output monitors for clinical practice have been introduced into the market, which do not require the insertion of pacemaker. These devices utilize different techniques to monitor, and each has their own sources of potential errors and degree of invasiveness. Hence, the risk of infection due to implantable medical devices is a constraint for the market. The other factors, such as the low level of accuracy with invasive cardiac output monitoring devices and the stringent FDA and validator regulations are the major restraints for the Middle East & Africa cardiac monitoring market.
Saudi Arabia Leads the Market in Middle East & Africa
In 2017, Saudi Arabia held the largest share in the cardiac monitoring market in the Middle East & Africa region due to high incidence and morbidity rate of cardiovascular disease.
Key Developments in the Market
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook